These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1566436)

  • 21. Platelet-derived growth factor and prostacyclin in kidney transplant rejection.
    Sinzinger H; Zidek T; Foegh ML
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):102-7. PubMed ID: 3303560
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of platelet activating factor antagonist WEB 2086 on the production of TNF from murine peritoneal macrophages.
    Ju DW; Zheng QY; Wang HB; Wang XF; Fang J
    Yao Xue Xue Bao; 1993; 28(10):721-7. PubMed ID: 8009983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
    Heuer HO
    Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170.
    Da Costa M; Metcalfe S; Calne RY
    Transplant Proc; 1990 Aug; 22(4):1945-6. PubMed ID: 2389490
    [No Abstract]   [Full Text] [Related]  

  • 25. Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes.
    Chávez-Cartaya RE; Metcalfe S; Ramirez-Romero P; Calne R; Jamieson NV
    Transplantation; 1994 May; 57(10):1440-4. PubMed ID: 8197604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The changes in prostaglandins after segmental pancreatic transplantation.
    Kawai T; Teraoka S; Hayashi T; Fuchinoue S; Honda H; Nakajima I; Suga H; Fujita S; Fujikawa H; Takahashi K
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1645-7. PubMed ID: 1989318
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation.
    Walcher F; Marzi I; Fischer R; Bauer M; Larsen R
    J Surg Res; 1996 Feb; 61(1):244-9. PubMed ID: 8769973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism.
    Tanaka M; Latinne D; Gianello P; Sablinski T; Lorf T; Bailin M; Nickeleit V; Colvin R; Lebowitz E; Sykes M
    Transplant Proc; 1994 Jun; 26(3):1326-7. PubMed ID: 8029926
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation.
    Thaiss F; Mihatsch MJ; Oberle G; Haberstroh U; Brecht HM; Stahl RA
    J Lab Clin Med; 1994 Dec; 124(6):775-81. PubMed ID: 7798789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a colonic PAF receptor.
    Longo WE; Carter JD; Chandel B; Niehoff M; Standeven J; Deshpande Y; Vernava AM; Polites G; Kulkarni AD; Kaminski DL
    J Surg Res; 1995 Jan; 58(1):12-8. PubMed ID: 7830400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostanoid metabolism in porcine liver transplantation: influence of warm ischemia.
    Kon H; Nakajima Y; Kimura J; Ito K; Tamura M; Saiki I; Nishibe M; Koike M; Abe H; Uchino J
    Transplant Proc; 1996 Jun; 28(3):1899-901. PubMed ID: 8658937
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical experience with platelet-activating factor antagonists. Past, present, and near future.
    Guinot P
    Clin Rev Allergy; 1994; 12(4):397-417. PubMed ID: 7743464
    [No Abstract]   [Full Text] [Related]  

  • 33. Xenograft rejection in human beings.
    Shons AR; Najarian JS
    Rev Surg; 1975; 32(1):70-2. PubMed ID: 122872
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of a platelet-activating factor antagonist at different doses given simultaneously with double-filtration plasmapheresis on cardiac xenograft survival.
    Taniguchi S; Kitamura S; Kawachi K; Fukutomi M; Yoshida Y
    Transplant Proc; 1994 Apr; 26(2):969-71. PubMed ID: 8171719
    [No Abstract]   [Full Text] [Related]  

  • 35. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the effect of plasmapheresis using human albumin or dextran 40 on the survival of pig-to-dog renal xenografts.
    Abouna GM; al-Abdullah IH; Ilia H; Kelley-Sullivan D
    Transplant Proc; 1996 Feb; 28(1):212-4. PubMed ID: 8644183
    [No Abstract]   [Full Text] [Related]  

  • 37. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A; Tahraoui L; Sedivy P; Cavero I
    J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF.
    Sirois P; Harczy M; Braquet P; Borgeat P; Maclouf J; Pradelles P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1033-7. PubMed ID: 2823554
    [No Abstract]   [Full Text] [Related]  

  • 39. [The content of thromboxane B2 and 6-ketoprostaglandin F1 alpha of the blood plasma in patients with psoriasis and children with allergic dermatoses].
    Polkanov VS; Vinogradov AI
    Vestn Dermatol Venerol; 1989; (1):11-3. PubMed ID: 2718610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of renal allografted dogs after limited therapy with cyclosporine and the PAF antagonist WEB 2170.
    Metcalfe SM; Watson CJ; Collier DG; DaCosta M; Friend PJ; Pollard SG; Luddington R; Calne RY
    Transplant Proc; 1991 Aug; 23(4):2219-20. PubMed ID: 1871852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.